CBS News @CBSNews
Eli Lilly announced it plans to cut prices on its most commonly prescribed insulin products by up to 70% and cap customers' out-of-pocket costs at $35 a month for those with commercial insurance who use its insulin. https://t.co/VAixUGCYFO — PolitiTweet.org